"Flutamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiandrogen with about the same potency as cyproterone in rodent and canine species.
| Descriptor ID |
D005485
|
| MeSH Number(s) |
D02.065.199.420 D02.092.146.113.420
|
| Concept/Terms |
Eulexin- Eulexin
- Euflex
- Drogenil
- Eulexine
|
Below are MeSH descriptors whose meaning is more general than "Flutamide".
Below are MeSH descriptors whose meaning is more specific than "Flutamide".
This graph shows the total number of publications written about "Flutamide" by people in this website by year, and whether "Flutamide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Flutamide" by people in Profiles.
-
The effects of testosterone on craniosynostotic calvarial cells: a test of the gene/environmental model of craniofacial anomalies. Orthod Craniofac Res. 2011 Aug; 14(3):149-55.
-
Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM. 2005 May; 98(5):349-56.
-
Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review. Urology. 2001 Apr; 57(4):727-32.
-
Comparative study of the clinical efficacy of two dosing regimens of flutamide. Mol Urol. 2000; 4(3):259-63;discussion 265.
-
Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs. Urology. 1997 Feb; 49(2):218-24.
-
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer. 1996 May 01; 77(9):1854-61.
-
Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells. Life Sci. 1996; 58(8):683-90.
-
Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer. Urology. 1995 Apr; 45(4):633-40.
-
Androgen regulation of thromboxane A2 receptors. Adv Prostaglandin Thromboxane Leukot Res. 1995; 23:251-3.
-
Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells. Circ Res. 1991 Sep; 69(3):638-43.